1110. Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards

BACKGROUND: Sluggish uptake of novel gram-negative antibiotics has jeopardized their future development and supply potentially risking patient lives. Understanding underutilization patterns might better inform unmet needs and market entry rewards. We studied patterns and drivers of use of recently U...

Descripción completa

Detalles Bibliográficos
Autores principales: Strich, Jeffrey R, Ullah Mishuk, Ahmed, Lawandi, Alexander, Diao, Guoqing, Warner, Sarah, Li, Willy, Demirkale, Cumhur Y, Mancera, Alex, Walker, Morgan, Yek, Christina, Neupane, Maniraj, De Jonge, Nathaniel, Kadri, Sameer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679413/
http://dx.doi.org/10.1093/ofid/ofad500.083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679413/
http://dx.doi.org/10.1093/ofid/ofad500.083

Ejemplares similares